Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review
Abstract
:1. Introduction
2. Materials and Methods
3. Results
3.1. Cognitive Training Programs
3.2. Cognitive Improvements after Cognitive Rehabilitation
3.3. Improvement in Non-Cognitive Outcomes after Cognitive Rehabilitation
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- McGrath, J.; Saha, S.; Chant, D.; Welham, J. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 2008, 30, 67–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Perälä, J.; Suvisaari, J.; Saarni, S.I.; Kuoppasalmi, K.; Isometsä, E.; Pirkola, S.; Partonen, T.; Tuulio-Henriksson, A.; Hintikka, J.; Kieseppa, T.; et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 2007, 64, 19–28. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saha, S.; Chant, D.; Welham, J.; McGrath, J. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005, 2, e141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oulis, P.; Konstantakopoulos, G.; Lykouras, L.; Michalopoulou, P.G. Differential diagnosis of obsessive-compulsive symptoms from delusions in schizophrenia: A phenomenological approach. World J. Psychiatry 2013, 3, 50–56. [Google Scholar] [CrossRef] [PubMed]
- Andreasen, N.C. The diagnosis of schizophrenia. Schizophr. Bull. 1987, 13, 9–22. [Google Scholar] [CrossRef] [Green Version]
- Keefe, R.S.; Fox, K.H.; Harvey, P.D.; Cucchiaro, J.; Siu, C.; Loebel, A. Characteristics of the MATRICS consensus cognitive battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr. Res. 2011, 125, 161–168. [Google Scholar] [CrossRef]
- Kontaxaki, M.I.V.; Kattoulas, E.; Smyrnis, N.; Stefanis, N.C. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum. Psychiatr. Psychiatr. 2014, 25, 27–38. [Google Scholar]
- Keefe, R.S.E.; Harvey, P.D. Cognitive impairment in schizophrenia. In Novel Antischizophrenia Treatments. Handbook of Experimental Pharmacology; Geyer, M., Gross, G., Eds.; Springer: Berlin/Heidelberg, Germany, 2012; Volume 213. [Google Scholar] [CrossRef]
- Cellard, C.; Reeder, C.; Paradis-Giroux, A.A.; Roy, M.A.; Gilbert, E.; Ivers, H.; Bouchard, R.C.; Maziade, M.; Wykes, T. A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia. Neuropsychol. Rehabil. 2016, 26, 321–344. [Google Scholar] [CrossRef] [Green Version]
- Field, J.R.; Walker, A.G.; Conn, P.J. Targeting glutamate synapses in schizophrenia. Trends Mol. Med. 2011, 17, 689–698. [Google Scholar] [CrossRef] [Green Version]
- Jann, M.W. Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis. Pharmacotherapy 2004, 24, 1759–1783. [Google Scholar] [CrossRef]
- Harvey, P.D. Cognitive and functional effects of atypical antipsychotic medications. J. Clin. Psychiatry 2006, 67, e13. [Google Scholar] [CrossRef]
- Keefe, R.S.E.; Bilder, R.; Davis, S.M.; Harvey, P.D.; Palmer, B.; Gold, J.M.; Meltzer, H.Y.; Green, M.F.; Capuano, G.; Stroup, T.; et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 2007, 64, 633–647. [Google Scholar] [CrossRef] [PubMed]
- Heinrichs, R.W. Cognitive improvement in response to antipsychotic drugs:neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 2007, 64, 631–632. [Google Scholar] [CrossRef] [PubMed]
- Lee, W.H.; Lee, W.K. Cognitive rehabilitation for patients with schizophrenia in Korea. Asian J. Psychiatry 2017, 25, 109–117. [Google Scholar] [CrossRef]
- Heilbronner, U.; Samara, M.; Leucht, S.; Falkai, P.; Schulze, T.G. The longitudinal course of schizophrenia across the lifespan: Clinical, cognitive, and neurobiological aspects. Harv. Rev. Psychiatry 2016, 24, 118–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Martínez, A.L.; Brea, J.; Rico, S.; de los Frailes, M.T.; Loza, M.I. Cognitive deficit in schizophrenia:from etiology to novel treatments. Int. J. Mol. Sci. 2021, 22, 9905. [Google Scholar] [CrossRef] [PubMed]
- Bor, J.; Brunelin, J.; d’Amato, T.; Costes, N.; Suaud-Chagny, M.F.; Saoud, M.; Poulet, E. How can cognitive remediation therapy modulate brain activations in schizophrenia? Psychiatry Res. Neuroimaging 2011, 192, 160–166. [Google Scholar] [CrossRef] [PubMed]
- Lee, W.K. Effectiveness of computerized cognitive rehabilitation training on symptomatological, neuropsychological and work function in patients with schizophrenia: Computerized cognitive rehabilitation training. Asia-Pac. Psychiatry 2013, 5, 90–100. [Google Scholar] [CrossRef] [PubMed]
- Grynszpan, O.; Perbal, S.; Pelissolo, A.; Fossati, P.; Jouvent, R.; Dubal, S.; Perez-Diaz, F. Efficacy and specificity of computer-assisted cognitive remediation in schizophrenia: A meta-analytical study. Psychol. Med. 2011, 41, 163–173. [Google Scholar] [CrossRef] [PubMed]
- Jaiswal, S.; Saxena, P.; Chowdhury, D.; Abhishek, P. Effectiveness of brief executive functions-based cognitive remediation in inpatient males with schizophrenia. Indian J. Soc. Psychiatry 2020, 36, 87. [Google Scholar] [CrossRef]
- Matsuda, Y.; Morimoto, T.; Furukawa, S.; Sato, S.; Hatsuse, N.; Iwata, K.; Kimura, M.; Kishimoto, T.; Ikebuchi, E. Feasibility and effectiveness of a cognitive remediation programme with original computerised cognitive training and group intervention for schizophrenia: A multicentre randomised trial. Neuropsychol. Rehabil. 2018, 28, 387–397. [Google Scholar] [CrossRef] [PubMed]
- Buonocore, M.; Spangaro, M.; Bechi, M.; Baraldi, M.A.; Cocchi, F.; Guglielmino, C.; Bianchi, L.; Mastromatteo, A.; Bosia, M.; Cavallaro, R. Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: Persistence after 5 years. Schizophr. Res. 2018, 192, 335–339. [Google Scholar] [CrossRef] [PubMed]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, 71. [Google Scholar] [CrossRef] [PubMed]
- Krzystanek, M.; Krysta, K.; Borkowski, M.; Skałacka, K.; Przybyło, J.; Pałasz, A.; Mucic, D.; Martyniak, E.; Waszkiewicz, N. The effect of smartphone-based cognitive training on the functional/cognitive markers of schizophrenia: A one-year randomized study. J. Clin. Med. 2020, 9, 3681. [Google Scholar] [CrossRef]
- Dubreucq, J.; Ycart, B.; Gabayet, F.; Perier, C.C.; Hamon, A.; Llorca, P.M.; Boyer, L.; Godin, O.; Bulzacka, E.; Andrianarisoa, M.; et al. Towards an improved access to psychiatric rehabilitation: Availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort. Eur. Arch. Psychiatry Clin. Neurosci. 2019, 269, 599–610. [Google Scholar] [CrossRef]
- Nemoto, T.; Takeshi, K.; Niimura, H.; Tobe, M.; Ito, R.; Kojima, A.; Saito, H.; Funatogawa, T.; Yamaguchi, T.; Katagiri, N.; et al. Feasibility and acceptability of cognitive rehabilitation during the acute phase of schizophrenia. Early Interv. Psychiatry 2021, 15, 457–462. [Google Scholar] [CrossRef]
- Peña, J.; Ibarretxe-Bilbao, N.; Sánchez, P.; Uriarte, J.J.; Elizagarate, E.; Gutierrez, M.; Ojeda, N. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia. J. Psychiatr. Res. 2018, 101, 21–27. [Google Scholar] [CrossRef]
- Fisher, M.; Holland, C.; Subramaniam, K.; Vinogradov, S. Neuroplasticity-based cognitive training in schizophrenia: An interim report on the effects 6 months later. Schizophr. Bull. 2010, 36, 869–879. [Google Scholar] [CrossRef] [Green Version]
- Mak, M.; Samochowiec, J.; Tybura, P.; Bieńkowski, P.; Karakiewicz, B.; Zaremba-Pechmann, L.; Mroczek, B. The efficacy of cognitive rehabilitation with RehaCom programme in schizophrenia patients. The role of selected genetic polymorphisms in successful cognitive rehabilitation. Ann. Agric. Environ. Med. 2013, 20, 5. [Google Scholar]
- McGurk, S.R.; Mueser, K.T.; DeRosa, T.J.; Wolfe, R. Work, recovery, and comorbidity in schizophrenia: A randomized controlled trial of cognitive remediation. Schizophr. Bull. 2009, 35, 319–335. [Google Scholar] [CrossRef]
- Wykes, T.; Huddy, V.; Cellard, C.; McGurk, S.R.; Czobor, P. A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. Am. J. Psychiatry 2011, 168, 472–485. [Google Scholar] [CrossRef] [PubMed]
- Green, M.F.; Kern, R.S.; Braff, D.L.; Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophr. Bull. 2000, 26, 119–136. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wykes, T.; van der Gaag, M. Is it time to develop a new cognitive therapy for psychosis--cognitive remediation therapy (CRT)? Clin. Psychol. Rev. 2001, 21, 1227–1256. [Google Scholar] [CrossRef]
- Hogarty, G.E.; Flesher, S.; Ulrich, R.; Carter, M.; Greenwald, D.; Pogue-Geile, M.; Kechavan, M.; Cooley, S.; DiBarry, A.L.; Garrett, A.; et al. Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior. Arch. Gen. Psychiatry 2004, 61, 866–876. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kluwe-Schiavon, B.; Sanvicente-Vieira, B.; Kristensen, C.H.; Grassi-Oliveira, R. Executive functions rehabilitation for schizophrenia: A critical systematic review. J. Psychiatr. Res. 2013, 47, 91–104. [Google Scholar] [CrossRef] [PubMed]
- Penadés, R.; González-Rodríguez, A.; Catalán, R.; Segura, B.; Bernardo, M.; Junqué, C. Neuroimaging studies of cognitive remediation in schizophrenia: A systematic and critical review. World J. Psychiatry 2017, 7, 34–43. [Google Scholar] [CrossRef] [PubMed]
First Author | Country of Origin | Publication Year | Study Design | Set of Diagnostic Criteria | Number of Participants | Mean Age ± SD, Sex Distribution |
---|---|---|---|---|---|---|
Bor et al. | France | 2011 | Randomized—single-blind parallel—arms design (part of a larger RCT study) | Schizophrenia according to DSM-IV-TR criteria | n = 32 Cognitive Remediation therapy Group/patients: n = 8 Non-Cognitive Remediation Therapy Group/patients: n = 9 Healthy controls: n = 15 | Cognitive Remediation therapy Group/patients: 30.5 (8.3), n = 6 males Non-Cognitive Remediation Therapy Group/patients: 28.5 (7.2), n = 6 males Healthy controls: 30.1 (7.5), n = 10 males |
Nemoto et al. | Japan | 2018 | Feasibility study | Schizophrenia according to DSM-IV criteria | n = 22 | 32.1 (10.36) n = 10 males |
Murthy et al. | USA and UK | 2012 | Open label multisite single sequence study | Schizophrenia according to DSM-IV-R criteria | n = 55 | 31.1 (7) n = 42 males |
Buonocore et al. | Italy | 2018 | Monocentric retrospective study | Schizophrenia according to DSM-IV-TR criteria | n = 60 CRT/SRT: n = 27 CRT/SRT+: n = 33 | CRT/SRT: n = 34.59 (10.27) CRT/SRT+: n = 35.20 (9.42) n = 35 males |
Krzystanek et al. | Poland | 2020 | Multicenter, open-label randomized trial | Paranoid schizophrenia according to ICD-10 criteria | n = 290 Study group: 199 Reference group: 91 | Study group: 32.0 (5.92), n = 114 males Reference group: 32.2 (6.94), n = 60 males |
Lee | Korea | 2013 | RCT | Schizophrenia according to DSM-IV criteria | n = 60 Cog-trainer group: 30 Usual Rehabilitation group: 30 | Cog-trainer group: 43.53 (4.87), n = 16 males Usual Rehabilitation group: 43.46 (3.53), n = 17 males |
Mohammadi et al. | Iran | 2014 | Pre-experimental study (pre-test and post-test in a single group) | Schizophrenia according to DSM-IV-TR criteria | n = 15 | Not specifically mentioned (Age: 18 or older) |
Cellard et al. | Canada | 2016 | Feasibility study (case study design) | Schizophrenia according to DSM-IV criteria | n = 3 | Case A:26 years old, male Case B: 26 years old, male Case C: 24 years old, male |
Fisher et al. | USA | 2010 | RCT | Schizophrenia according to DSM-IV criteria | n = 32 Computer games group: n = 10 Control group: n = 12 Targeted Cognitive Training group: n = 10 | Computer games group: 46.90 (9.17), n = 8 males Control group: 48.50 (6.94), n = 10 males Targeted Cognitive Training group: 42.90 (8.06), n = 7 males |
Matsuda et al. | Japan | 2016 | RCT | Schizophrenia according to DSM-IV-TR criteria | n = 62 Cognitive Rehabilitation group: n = 31 Control group: n = 31 | Cognitive Rehabilitation group: 36.39 (8.53), n = 17 males Control group: 37.77 (9.12), n = 18 males |
Mak et al. | Poland | 2013 | RCT | Paranoid schizophrenia according to ICD-10 criteria | n = 81 Research group: n = 41 Control group: n = 40 | Research group: 34 (11.07), n = 19 males Control group: 39 (12.99), n = 18 males |
Dubreucq et al. | French | 2019 | FACE-SC-Longitudinal study | No specifically mentioned at this article | n = 183 | 33.91 (10.26) n = 144 males |
Jaiswal et al. | India | 2020 | Quasi—experimental design (preliminary intervention study) | Paranoid schizophrenia according to ICD-10 criteria | n = 12 Intervention group: n = 6 Control group: n = 6 | Intervention group: 31.33 (2.34), n = 6 males Control group: 28.50 (5.58), n = 6 males |
Author (Year) | Study Settings | Cognitive Rehabilitation Training | Training Intensity | Trained Modules | Significant Cognitive Improvements after Rehabilitation | Significant Non- Cognitive Improvements after Rehabilitation |
---|---|---|---|---|---|---|
Bor et al. (2011) | Outpatients (stable doses of antipsychotic medications for at least 3 months before the inclusion in the study) | RehaCom software | Total duration 7 weeks, 14 individual sessions (2 h length) | Attention/concentration, working memory, logical thinking, executive functions | Strong improvements in reasoning and attention (variations in cerebral functioning at fMRI) | Not mentioned |
Nemoto et al. (2018) | Inpatients | Cognitive rehabilitation programs workbook style | Total duration 8 weeks, 20 min. per day | Exercises to improve cognitive function, interpersonal relationships, social context | Feasibility and accessibility of cognitive rehabilitation during the acute phase of schizophrenia | Improvements in global functioning |
Murthy et al. (2011) | Outpatients (clinically stable in the previous 6 months and on regular antipsychotic medication) | BFP—computerized intervention | ≥32 BFP training (≈40 sessions, at least 1 h, 5 times/week) sessions over 8–10 weeks | Speed and accuracy of auditory information processing | Significant effect on auditory processing speed | No significant effects on cognitive performance in general and functional capacity |
Buonocore et al. (2018) | Outpatients (clinically stable in the last 3 months) | Computerized cognitive remediation therapy, performed with the Cogpack software and SRT | 3 months of 3 1 h sessions a week and 6 months SRT and acute and 5-year follow-up assessment | Domain-specific neurocognitive exercises depending on patients’ impairments and graded difficulty | Cognitive abilities remained stable after 5 years in both groups (except of psychomotor speed and coordination) | Not mentioned |
Krzystanek et al. (2020) | Outpatients (in symptomatic remission and stable schizophrenia symptoms at a mild level for at least 6 months prior study enrolment) | Self-administered cognitive training using a smartphone-based application (MONEO) | Cognitive training twice a week (study group) with increasing levels of difficulty and limited 3 cognitive trainings (reference group) | Not specifically mentioned, measurements of response time, rate of correct answers, rate of incorrect answers and rate of lack of reaction | Significant cognitive improvement in both the rate of correct answers and cognitive fatigability and slight improvement in the rate of incorrect answers | Significant improvement in the clinical condition, decreased schizophrenia symptoms |
Lee (2013) | Inpatients (stable dose of antipsychotic therapy for at least 6 months) | Computerized cognitive training employed Cog-trainer software | Cog-trainer group: 20 sessions, 1 h, one or two times a week over 3 months UR group: 15 months duration | Cog-trainer group: attention and working memory UR group: social skills, vocational, recreational functioning, psychoeducation | Significant improvement in attention, concentration and working memory | Improvement in the work quality subscale and work habits of the work behavior inventory |
Mohammadi et al. (2014) | Outpatients (clinically stable) | RehaCom software | 20 individual sessions each 60 min, 2 sessions/week for 18 weeks | Attention/concentration, working memory and executive functions | Improvements in attention/vigilance, working memory and prospective and retrospective memory | No improvements in positive or negative symptoms of schizophrenia |
Cellard et al. (2016) | Recruited from clinical settings without acute psychotic symptoms | Computerized cognitive remediation—CIRCuiTS | 1 h sessions at least 3 days/week, for 40 sessions total | Attention, memory, executive functioning, and metacognitive skills | Improvements in verbal and visual episodic memory | Not specifically mentioned |
Pena et al. (2018) | Not specifically mentioned (inpatients and outpatients probably from a previous RCT from which the sample was recruited) | REHACOP group: Cognitive rehabilitation based on paper and pencil tasks, role playing, active group discussions Control group: occupational group activities | 4 months total duration, 90 min sessions, 3 days/week both groups | REHACOP group: attention, memory, language, executive functions, and social cognition control group: occupational activities | Improvements on processing speed and verbal memory, working memory, executive functions, emotion perception, theory of mind, social perception | Negative symptoms of schizophrenia |
Fisher et al. (2010) | Not specifically mentioned (clinically stable patients recruited from mental health settings in the community) | TCT (software developed by Posit-Science, Inc.) and commercially available computerized games | TCT group: 12 participants completed 50 h training—10 participants completed 100 h training CG group: 5 days/week, 1 h/day (4–5 games/day) | TCT group: auditory exercises, visual system, categorization, prediction, association of information from auditory and visual stimuli CG group: 16 different games, e.g., visuospatial puzzle games, clue-gathering mystery games | Both TCT groups showed significant improvements in verbal learning/memory, cognitive control TCT-100 h training group showed improvements in processing speed and global condition | Not mentioned |
Matsuda et al. (2016) | Outpatients | Original computer programme JCORES | Cognitive remediation group: 60 min., 2 sessions/week, 12 weeks total duration (plus 1/week metacognition enhancement and strategies teaching) control group: 12 weeks total; duration | attention, psychomotor speed, learning, memory, executive functions, verbal memory, verbal fluency, reasoning, problem solving, metacognition, strategies | Improvements on verbal memory and composite cognitive score | Improvements on general psychopathology on the positive and negative symptoms syndrome scale |
Mak et al. (2013) | Not specifically mentioned (stable at remission period and pharmacological monotherapy) | RehaCom programme | 16 sessions, twice/week (40 min.) 60 days total duration | Attention/concentration, topological memory | Moderate improvement in cognitive functioning (combined with pharmacological treatment and psychiatric rehabilitation) | Not mentioned |
Dubreucq et al. (2019) | Not specifically mentioned—recruited from FACE-SZ cohort | CRT | At least 1 PI during the 1-year follow-up | Not specifically mentioned | Moderate improvement in sustained attention, working memory, high improvement in reactive mental flexibility (combined with PI intervention) | Moderate improvement in negative symptoms, mild effect on clinical global severity and on the level of insight into illness (combined with PI intervention) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zoupa, E.; Bogiatzidou, O.; Siokas, V.; Liampas, I.; Tzeferakos, G.; Mavreas, V.; Stylianidis, S.; Dardiotis, E. Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review. Neurol. Int. 2023, 15, 12-23. https://doi.org/10.3390/neurolint15010002
Zoupa E, Bogiatzidou O, Siokas V, Liampas I, Tzeferakos G, Mavreas V, Stylianidis S, Dardiotis E. Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review. Neurology International. 2023; 15(1):12-23. https://doi.org/10.3390/neurolint15010002
Chicago/Turabian StyleZoupa, Elli, Olympia Bogiatzidou, Vasileios Siokas, Ioannis Liampas, Georgios Tzeferakos, Venetsanos Mavreas, Stelios Stylianidis, and Efthimios Dardiotis. 2023. "Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review" Neurology International 15, no. 1: 12-23. https://doi.org/10.3390/neurolint15010002
APA StyleZoupa, E., Bogiatzidou, O., Siokas, V., Liampas, I., Tzeferakos, G., Mavreas, V., Stylianidis, S., & Dardiotis, E. (2023). Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review. Neurology International, 15(1), 12-23. https://doi.org/10.3390/neurolint15010002